Glucose levels in non-diabetic patients. Is it a prognostic factor in acute coronary syndrome?;Niveles de glucemia en pacientes no diabéticos. ¿Es un factor pronóstico en el síndrome coronario agudo?

Revista Clinica Espanola

Volumn 206, Issue 6, 2006, Pages 271-275

  Facila Rubio L ^a   Bertomeu Gonzalez V ^b   Sanchis J ^b   Bodi V ^b   Nunez J ^b   Llacer A ^b   Bellido, V ^a  

^a Servicion de Cardiología   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Diabetes; Myocardial ischemia; Prognosis

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR;

EID: 33746317548     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13088586     Document Type: Article

References (22)

1. Genuth S, Alberdi KG, Bennett P, Buse J, Defrondo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7.
2. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004;164:2147-55.
3. Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD, et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet. 1999;354:622-5.
4. Barzilay JI, Kronmal RA, Gottdiener JS, Smith NL, Burke GL, Tracy R, et al. The association of fasting glucose levels with congestive heart failure in diabetic adults ≥ 65 years: the Cardiovascular Health Study. J Am Coll Cardiol. 2004;43:2236-41.
5. Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, et al. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese- American with normal fasting glucose. Diabetes Care. 2001;24:39-44.
6. Jarrett RJ. The cardiovascular risk associated with impaired glucose tolerance. Diabet Med. 1996;13:S15-S9.
7. Pan XR, Hu YH, Li GW, Liu PA, Bennett PH, Howard BV. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study. Diabetes Care. 1993;16:150-6.
8. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol. 1992;135:1321-30.
9. Fisman EZ, Motro M, Tenebaum A, Boyko V, Mandelzweig L, Behar S. Impaires fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker of a worse prognosis. Am J Heart. 2001;141:485-90.
10. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Bittner V, Cauley JA, et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery heart disease. Am Intern Med. 2005; 142:813-20.
11. Alpert JS, Thygensen K, Antman E, Bassand JP. Myocardial infarction redefined -a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the definition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-69.
12. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease accross Europe. The Euro heart Survey on diabetes and the heart. Eur Heart J. 2004;25:1880-90.
13. Pyorala K, Lehto S, De BD, De SJ, Sans S, Keil U, et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from EUROASPIRE I AND II surveys. Diabetologia. 2004;47: 1257-65.
14. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AF, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary heart syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:1190-201.
15. Carlson LA, Wahlberg F. Serum lipids, intravenous glucose tolerance and their interrelation studied in ischaemic cardiovascular disease. Acta Med Scan. 1996;180:307-15.
16. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed). 1986;293:917-22.
17. Oswald GA, Smith CC, Delamothe AP, Betteridge DJ, Yudkin JS. Raised concentrations of glucose and adrenaline and increased in vivo patelet activation after myocardila infarction. Br Heart J. 1988;59:663-71.
18. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in convencionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626-32.
19. Arcavi L, Behar S, Caspi A, Reshef N, Boyko V, Knobler H. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery desease: results from the Bezafibrate Infarction Prevention (BIP) study. Am Heart J. 2004;147:239-45.
20. Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR. Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev. 2005;13:223-30.
21. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation. 2005;111:754-60.
22. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005;22:1321-5